FDA record · warning letter

FDA warning letter: cheaptrustedpharmacy.com (Jul 29, 2025)

On Jul 29, 2025, FDA issued a warning letter to cheaptrustedpharmacy.com under the subject "Notice of Unlawful Sale of Unapproved Drugs to United States Consumers Over the Internet". It names semaglutide. Open: no closeout letter published as of Oct 3, 2026.

Julian CaraulaniFounder, PriceTracker GLP-1FDA record read Oct 3

Status: Open: no closeout letter published as of Oct 3, 2026.

What FDA’s record states

FDA record for the warning letter to cheaptrustedpharmacy.com
Field	What FDA’s record states	Source
Recipient	cheaptrustedpharmacy.com	FDA letter
Location	Not published by FDA	n/a
Letter date	Jul 29, 2025	FDA letter
Posted by FDA	Sep 23, 2025	FDA index
Issuing office	Center for Drug Evaluation and Research (CDER)	FDA letter
Subject	Notice of Unlawful Sale of Unapproved Drugs to United States Consumers Over the Internet	FDA letter
MARCS-CMS number	705501	FDA letter
GLP-1 drugs named	Semaglutide	FDA letter
Response letter	Not published by FDA	FDA letter
Closeout letter	Not published by FDA	FDA letter

“FDA has observed that www.cheaptrustedpharmacy.com introduces into interstate commerce certain drugs for which the FDA-approved version is subject to a Risk Evaluation and Mitigation Strategy (REMS) program, is an opioid, semaglutide, an injectable, and/or is indicated to treat serious conditions such as HIV/AIDS or cancer.”FDA warning letter to cheaptrustedpharmacy.com, Jul 29, 2025 · read the full letter on fda.gov ↗

What this is and is not.A warning letter is FDA’s statement of what it considers significant violations. It is an allegation, not a court finding, and the firm can respond. A closeout letter is posted when FDA confirms the violations were corrected.

Source

Every field above is copied from FDA’s page for this letter, read Oct 3, 2026. The letter on fda.gov ↗ · All 161 GLP-1 warning letters